An unusual cause of rhabdomyolysis in the patients with Parkinson’s disease: A report of two cases
Objective: To describe unusual cause of rhabdomyolysis in the two patients with Parkinson’s disease (PD). Background: Levodopa-induced dyskinesia (LID) is usually seen in advanced stage…Mindfulness Training to Reduce Anxiety in Parkinson’s Disease: A Cautionary Tale about Wearable Technology
Objective: This study aimed to determine the feasibility of using a non-pharmacologic intervention (mindfulness training; MT) administered with a wearable tracker to alleviate anxiety through…MIBG myocardial scintigraphy identifies premotor PD/DLB during a negative DAT scan period
Objective: It is unknown which marker is useful to identify the premotor phase PD/DLB. We recently reported four patients who, during a negative DAT scan…Specific chemosensory pattern in Parkinson’s disease
Objective: Our objective was to investigate the trigeminal pathway by measuring intranasal and central electrophysiological recordings in response to a specific trigeminal stimulus in patients…Association between alteration in social cognition and impulse control disorder in Parkinson’s disease
Objective: To explore and compare social cognition between patients with Parkinson's disease (PD) and healthy participants. Secondarily, to explore whether social cognition is related to…Visuoperceptual impairment: a key feature in the diagnosis of corticobasal degeneration
Objective: We present a patient with a neurodegenerative disease where visuoperceptual testing led to a new working diagnosis of corticobasal degeneration (CBD) Background: CBD is a…Procedural Memory Changes of Parkinson’s Disease Patients Post Participation in Boxing
Objective: Can participation in a Rock Study Boxing program improve procedural memory in people with Parkinson’s disease (PD)? Background: Procedural memory is important for daily…Neuropsychological changes over the first 6 years of Parkinson’s disease in the ICICLE-PD cohort
Objective: To determine the longitudinal differences in cognitive tests in participants with Parkinson’s disease (PD), and the neuropsychological tests most sensitive to change over and…Plasma Soluble ST2 (sST2) levels are Higher in Neurodegeneration and Associate with PD Cognition
Objective: As plasma IL-33 levels are too low to accurately quantify, we measured plasma sST2 as a surrogate marker for IL-33 in samples from healthy…Cognitive impairment in Parkinson’s Disease: A cross-sectional association study
Objective: To characterize the presence and clinical presentation of PD-MCI and PDD in patients with idiopathic PD, examining motor and non-motor features and determining factors…
- « Previous Page
- 1
- …
- 135
- 136
- 137
- 138
- 139
- …
- 217
- Next Page »